What to try for a sore or stiff shoulder

What to try first

Reduce the task that repeatedly triggers the ache. Movement doesn't need to stop if easy use feels all right.

Gentle motion can limit added stiffness. Guided exercise may build strength for dressing, driving, and reaching.

Some medicines can ease soreness, but other health needs guide the choice. Tell your doctor about stomach, kidney, or heart trouble before choosing a pain medicine.

Also review your prescriptions and any past medicine reactions. Ask which option is safer with those facts in mind.

Ask when home care has had enough time. That'll help you judge change without waiting forever.

What to ask about PRP

The letters PRP mean platelet-rich plasma, and the process begins with a blood draw. A clinic machine spins the blood so more platelets remain in the liquid, and those blood parts carry growth factors; the liquid is then placed near your sore shoulder with a needle.

Concentrated PRP starts the same way but keeps still more platelets. Ask whether that difference changes the expected benefit, cost, or recovery time.

Research on PRP gives different answers for different shoulder problems. Ask what people could do afterward, not only whether their pain score changed.

I'd want the full price in writing before deciding. The talk also needs to cover exercise, other care, and the chance of little change.

When to discuss surgery

A serious fall or an arm that suddenly weakens may bring surgery into the talk. It may also come up when arthritis causes marked stiffness and lost use.

Ask what the operation is meant to change. You'll need plain details about driving, dressing, sleep, and help at home.

Needing an operation doesn't mean earlier care failed, and delay isn't always safe. The exam and scan can show whether time matters for your shoulder.

Sources

1. The Cochrane review of corticosteroid injections for shoulder pain included 26 trials (median 52 participants each) and concluded there is LITTLE overall evidence to guide treatment: subacromial injection for rotator cuff disease showed a small benefit over placebo in some trials but no benefit over NSAIDs when three trials were pooled, and intra-articular injection for adhesive capsulitis showed a possible early benefit that was 'small and not well-maintained'.

   Buchbinder R, et al. — Corticosteroid injections for shoulder pain.. Cochrane Database Syst Rev, 2003. DOI: 10.1002/14651858.CD004016.

2. A meta-analysis of eight randomized trials of PRP for rotator cuff tendinopathy concluded PRP was a safe and effective intervention for long-term pain control and shoulder function - but the review itself records that PRP preparation and injection technique varied between studies and that the control interventions differed (saline in four trials, rehabilitation or dry needling in the other four), which is why its conclusion sits alongside more cautious reviews rather than settling the question.

   A Hamid MS, et al. — Platelet-rich plasma for rotator cuff tendinopathy: A systematic review and meta-analysis.. PLoS One, 2021. DOI: 10.1371/journal.pone.0251111.

3. A randomized trial in the New England Journal of Medicine compared physical therapy against intra-articular glucocorticoid injection for knee osteoarthritis and found physical therapy produced better WOMAC outcomes at one year. When a clinic offers an injection, the comparator that matters is not 'nothing' - it is a course of supervised exercise.

   Deyle GD, et al. — Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee.. The New England journal of medicine, 2020. DOI: 10.1056/NEJMoa1905877.

4. In a 2-year RCT, intra-articular triamcinolone given every 12 weeks for knee OA produced significantly GREATER cartilage volume loss than saline, with no significant pain benefit. The most widely used joint injection in medicine is itself associated with structural harm on repeat dosing - relevant context when a clinic frames a biologic as 'the alternative to steroid shots'.

   McAlindon TE, et al. — Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.. JAMA, 2017. DOI: 10.1001/jama.2017.5283.

5. The AAOS third-edition clinical practice guideline for non-arthroplasty management of knee osteoarthritis is the orthopedic profession's own GRADE-style appraisal of the same options a regenerative clinic sells; it is the benchmark against which any 'regenerative' claim on this topic should be read, and it rates the strongest support for exercise, weight loss and self-management rather than for injectables.

   Brophy RH, et al. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. The Journal of the American Academy of Orthopaedic Surgeons, 2022. DOI: 10.5435/JAAOS-D-21-01233.

6. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.